Re: Effect of silymarin on streptozotocin-nicotinamide-induced type 2 diabetic nephropathy in rats

Iranian Journal of Kidney Diseases

Volumn 7, Issue 5, 2013, Pages 414-415

  Nasri, Hamid ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; DEFEROXAMINE; GENTAMICIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; IRON DEXTRAN; METFORMIN; NICOTINAMIDE; RESVERATROL; SILYMARIN; STREPTOZOCIN; URIC ACID;

ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; CREATININE BLOOD LEVEL; DIABETES CONTROL; DIABETIC NEPHROPATHY; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; EXPERIMENTAL STUDY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; INSULIN SENSITIVITY; IRON METABOLISM; LETTER; NEPHROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN URINE LEVEL; RENAL PROTECTION; STREPTOZOCIN DIABETES; TREATMENT OUTCOME; URIC ACID BLOOD LEVEL; URINE VOLUME;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; MALE; PROTECTIVE AGENTS; SILYMARIN;

EID: 84884758908     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Letter

References (16)

1. Sheela N, Jose MA, Sathyamurthy D, Kumar BN. Effect of silymarin on streptozotocin-nicotinamide-induced type 2 diabetic nephropathy in rats. Iran J Kidney Dis. 2013;7:117-123.
2. Nematbakhsh M, Pezeshki Z, Moaeidi B, et al. Protective role of silymarin and deferoxamine against iron dextran-induced renal iron deposition in male rats. Int J Prevent Med. 2013;4:286-291.
3. Tolouian R, Hernandez GT. Prediction of Diabetic Nephropathy: The need for a sweet biomarker. J Nephropathol. 2013;2:4-5.
4. Rahimi Z. ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy. J Nephropathol.2012;1:143-151.
5. Rouhi H, Ganji F. Effect of N-acetyl cysteine on serum Lipoprotein (a) and proteinuria in type 2 diabetic patients. J Nephropathol. 2013;1:61-66.
6. Baradaran A. Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues. J Nephropathol. 2012;1:126-129.
7. Hundal RS, Krssak M, Dufour S, et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes. 2000;49:2063-2069.
8. Tavafi M. Diabetic nephropathy and antioxidants. J Nephropathol. 2013;2:20-27.
9. Morales AI, Detaille D, Prieto M, et al. Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway. Kidney Int. 2010;77:861-869.
10. Sahni N, Gupta KL. Dietary antioxidents and oxidative stress in predialysis chronic kidney patients. J Nephropathol. 2012;1:134-142.
11. Amini FG, Rafieian-Kopaei M, Nematbakhsh M, Baradaran A, Nasri H. Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats. J Res Med Sci. 2012;17:621-625.
12. Rafieian-Kopaei M, Baradaran A, Merrikhi A, Nematbakhsh M, Madihi Y, Nasri H. Efficacy of Co-administration of Garlic Extract and Metformin for Prevention of Gentamicin-Renal Toxicity in Wistar Rats: A biochemical study. Int J Prevent Med. 2013;4:258-264.
13. Nasri H, Nematbakhsh M, Rafieian-kopaei M. Ethanolic garlic extract attenuates gentamicin-induced nephrotoxicity in Wistar rats. Iran J Kidney Dis. 2013. In press.
14. Bruckbauer A, Zemel MB. Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity. Diabetes Metab Syndr Obes. 2013;6:93-102.
15. Rafieian-Kopaei M, Nasri H, Nematbakhsh M, et al. Erythropoietin ameliorates gentamicin-induced renal toxicity: A biochemical and histopathological study. J Nephropathol. 2012;1:109-116.
16. Nasri H. Hypertension and renal failure with right arm pulse weakness in a 65 years old man. J Nephropathol. 2012;1:130-133.